Urgent call for affordable diabetes treatment: Senate hearing highlights pharmaceutical markup crisis

By Phindile Nqumako | Published Sep 27, 2024

Pharmaceutical corporations Eli Lilly, Novo Nordisk, and Sanofi have been challenged by Doctors Without Borders to take urgent action to increase access to diabetes medicines everywhere by dropping prices and not blocking generic manufacturers from entering the market to help meet the global demand for medication. ​